Health Care/Hospital
NEWLY-LAUNCHED AMAZFIT ACTIVE AND AMAZFIT ACTIVE EDGE INTRODUCE A STYLISH WAY TO STAY ACTIVE & STAY HEALTHY
Tailored for the modern-day city consumer, the Amazfit Active and Amazfit
Active Edge seamlessly blend style, functionality, and health, redefining what
it means to live an active lifestyle.
MILPITAS, Calif., Oct. 25, 2023 /PRNewswire/ -- Amazfit
2023-10-25 20:00
1689
ESAOTE's new S-scan Open redefines excellence in magnetic resonance imaging
GENOA, Italy, Oct. 25, 2023 /PRNewswire/ -- Esaote, a leading Italian company
in ultrasound, dedicated MRI and healthcare IT,presents S-scan Open, the new
configuration of S-scan,one of its best-selling MRI systems.
2023-10-25 20:00
1997
Metabolon and Genomics England Announce Partnership to Characterize Hundreds of Rare Diseases and Advance Rare Disease Diagnosis
Alliance aims to enable the discovery of novel rare disease biomarkers to support faster diagnosis and more effective treatments MORRISVILLE, N.C., and LONDON, Oct. 25, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life sc...
2023-10-25 19:57
1167
FUTURE INVESTMENT INITIATIVE INSTITUTE RESOLVES TO REMOVE 5.4 TRILLION INVESTMENT GAP IN EMERGING MARKETS
RIYADH, Saudi Arabia, Oct. 25, 2023 /PRNewswire/ -- At the Future Investment
Initiative (FII) inRiyadh today, a global summit, leaders and investors have
today resolved to tackle ESG shortcomings in the form of a Resolution to
Increase ESG Investment in Emerging Markets
2023-10-25 15:46
1680
AMS BioteQ Makes Debut at Medical Japan 2023: Bringing Innovative Healthcare into New Horizons
TAIPEI, Oct. 25, 2023 /PRNewswire/ -- Medical Japan Tokyo was held grandly from October 11 to 13, gathering medical professionals, manufacturers, medical institutions, and research units from around the world. AMS BioteQ Co., Ltd. made its first appearance in the exhibition and became one of the ...
2023-10-25 13:06
1393
Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development
EAST RUTHERFORD, N.J, Oct. 25, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry has been selected as the winner of the API Development Award, presented at the CPhI Pharma Awards inBarcelona, Spain....
2023-10-25 04:18
1669
Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma
--Industry veteran to lead growth for company's CDMO and pharmaceutical supply divisions, NovaCina and LumaCina-- MIAMI and PERTH, Australia, Oct. 25, 2023 /PRNewswire/ -- Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, announced today thatCyrus K. Mirsaidi is ...
2023-10-24 23:17
1305
Wolters Kluwer Applauded by Frost & Sullivan for Improving Healthcare Efficiencies, Quality, and Outcomes and for Its Competitive Strategies
Wolters Kluwer uniquely leverages its expertise to meet market and customer needs, positioning it to capitalize on new growth opportunities and lead in healthcare conversational AI. SAN ANTONIO, Oct. 24, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the conversational artificial inte...
2023-10-24 21:30
1270
OrbiMed Raises $4.3 Billion Across Private Investment Funds
NEW YORK, Oct. 24, 2023 /PRNewswire/ -- OrbiMed, a global healthcare investment firm, is pleased to announce it has raised more than$4.3 billion in commitments for its latest private investment funds, including OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit O...
2023-10-24 19:30
1342
Life Molecular Imaging and Sinotau Pharmaceutical Group Announce the Regulatory Approval of their Amyloid PET Imaging Radiopharmaceutical Neuraceq® in China
First Amyloid PET Tracer Received Regulatory Approval in China BERLIN and BEIJING, Oct. 24, 2023 /PRNewswire/ -- Life Molecular Imaging (LMI) and Sinotau Pharmaceutical Group are pleased to announce Neuraceq® (with Chinese trade name 欧韦宁®, florbetaben F-18 injection) has received regulatory appr...
2023-10-24 16:00
1225
SID BIO Inc. to Debut at 'in-cosmetics asia 2023,' the World's Largest Cosmetics Ingredients Expo
SEOUL, South Korea, Oct. 24, 2023 /PRNewswire/ -- Korean K-beauty specialist company SID BIO Inc. will make its global market debut at 'in-cosmetics asia 2023,' the world's largest cosmetics ingredients expo, taking place from November 7-9 at the Bangkok International Trade & Exhibition Centre (BI...
2023-10-24 15:50
1248
BioWorld by Clarivate Examines Impact of Emerging Medicines on Obesity
Three-part, in-depth analysis of biopharma investments in obesity medications highlights potential impact onpatient population historically faced with limited options LONDON, Oct. 24, 2023 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a global leader in connecting people and ...
2023-10-24 15:00
1181
Recbio appeared at the 14th China (Taizhou) International Pharmaceutical Fair
TAIZHOU, China, Oct. 24, 2023 /PRNewswire/ -- From October 19 to 22, the 14th China (Taizhou) International Pharmaceutical Fair, sponsored by the China Chamber of International Commerce and hosted by the Taizhou Municipal People's Government andJiangsu Branch of the China Council for the Promotio...
2023-10-24 13:39
1526
Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards
SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics
2023-10-24 12:00
1216
Cellomics announces Mr. Andy A. Liu as new Group CEO of the Company
Hong Kong, Oct. 24, 2023 /PRNewswire/ -- Cellomics, the leader in liquid biopsy technology for cancer screening and precision diagnosis, is pleased to announce the appointment of Mr.Andy A. Liu as the new Group CEO of the company. With over 25 years of healthcare experience, Mr. Liu brings a weal...
2023-10-24 12:00
1961
CCTV+: Jianchangbang Pharmacy: A Thousand Years of Tradition and Excellence
BEIJING, Oct. 24, 2023 /PRNewswire/ -- As a living legacy of Jiangxi's rich culture of traditional Chinese medicine (TCM), the respected brand, Jianchangbang Pharmacy, carries forward the splendor of Chinese medical wisdom. It is a renowned sect of theSouth China ancient TCM school and TCM prepar...
2023-10-24 11:51
1448
Based on recent data presented at 2023 ESMO, the innovative TROP2 ADC SKB264 (MK-2870) shows promising prospects for the treatment of patients with HR+/HER2- metastatic breast cancer who have undergone multiple prior lines of therapy , and its clinical development in other solid tumors is also advancing steadily
CHENGDU, China, Oct. 24, 2023 /PRNewswire/ -- Human trophoblastic cell surface antigen 2 (TROP2) exhibits high expression in numerous solid tumors, making it a prominent target in recent oncology studies. The progress in the development of Antibody-Drug Conjugates (ADCs) against this target has ...
2023-10-24 10:19
2190
Council of ASEAN Chief Justices reflect milestones and achievements over the past 10 years, and chart strategic agenda
SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- The Council of ASEAN Chief Justices (CACJ) held its inaugural retreat on 20 October to reaffirm the ASEAN Judiciaries' strategic and cohesive approach towards deepening judicial cooperation and upholding the Rule of Law. It was hosted by the Malaysian Jud...
2023-10-24 10:07
1286
Alphamab Oncology updated data from two studies of KN026 in combination with docetaxel for HER2-positive breast cancer at ESMO
* KN026 combined with docetaxel has significant efficacy in the first-line treatment of HER2-positive recurrent or metastatic breast cancer, with mPFS of 26.9 months and 24-month OS rate of 84.2%. * KN026 combined with docetaxel has significant efficacy and good tolerability in the neoadjuvan...
2023-10-24 08:41
3027
Alphamab Oncology Announces New Data from Multiple Studies of KN046 with Lung Cancer and Thymic Carcinoma at ESMO
* KN046 showed encouraging efficacy result especially in OS benefit (mOS: 20.2 months) in advanced NSCLC with EGFR sensitivity mutation who progressed after EGFR-TKI(s). * KN046 showed encouraging efficacy result especially in OS benefit (mOS: 13.3months) in advanced NSCLC with EGFR sensitivi...
2023-10-24 08:41
1356
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2931
